| 1 |
33706759 | Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19. | 2021 Mar 11 |
1 |
| 2 |
32729248 | In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression. | 2020 Jul |
1 |
| 3 |
29731719 | rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling. | 2018 |
2 |
| 4 |
25089563 | The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rho kinase pathway. | 2015 Jan 20 |
1 |
| 5 |
25435005 | Therapeutic effect of human umbilical cord mesenchymal stem cells modified by angiotensin-converting enzyme 2 gene on bleomycin-induced lung fibrosis injury. | 2015 Apr |
8 |
| 6 |
24168260 | Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway. | 2014 Apr |
2 |
| 7 |
18441099 | Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis. | 2008 Jul |
1 |